StreetAlpha.app
Home › Stocks › CRBP

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Healthcare

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a Healthcare stock tracked by StreetAlpha. CRBP reports earnings on Wed, Nov 11, 2026. Over the past 90 days StreetAlpha recorded 1 whale options trade in CRBP, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print.

AI Auto Pilots
Is CRBP in one of our four AI portfolios? Sign in free to see
Next report
Nov 11
2026 · Time not announced
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated CRBP in the past 90 days, not enough for a consensus
Average 12-month target
Price targets are not shown on this page right now.
Latest rating changes
OppenheimerTarget lowered
Aug 7Buy—
HC Wainwright & Co.Target lowered
Aug 7Buy—
MizuhoTarget lowered
Jun 23Buy—
OppenheimerMaintained
Jun 17Buy—
WedbushMaintained
May 27Buy—
DateFirmActionRatingPrice target
Aug 7OppenheimerTarget loweredBuy—
Aug 7HC Wainwright & Co.Target loweredBuy—
Jun 23MizuhoTarget loweredBuy—
Jun 17OppenheimerMaintainedBuy—
May 27WedbushMaintainedBuy—
Loading…

Whale Options Flow

90D
Total alerts
1
Bullish
1
100%
Bearish
0
0%
Date span
Sep 15 – Sep 15
Loading…

Dark Pool

30D
Prints
1
Notional
—
Largest print
—
Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRBP is in one of them and how their past CRBP trades turned out.

CRBP in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CRBP in an article yet. Here's the latest on the wider market.